ATLANTA, GA – June 23, 2016: Bethany Bray, Chief Executive Officer and Co-Founder of AutoCruitment will be a featured presenter and panelist at the DIA Annual Meeting in Philadelphia in June. Drug Information Association (DIA) is the only global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide and has become an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.
The session entitled “Patient Recruitment in Rare Diseases: Ideas and Framework for out-of-the-Box Exploration”, will explore the challenges of recruiting patient participants in clinical studies involving rare diseases where populations are small and geographically dispersed. The aim of the session is to “catalyze unconventional thinking, judge industry leaders various recruitment strategies and to provide a framework to organize innovative recruitment ideas.” The discussion will focus on patient recruitment, retention, engagement and clinical trial designs.
Bethany’s initial presentation, “Direct-to-Patient Digital Recruitment: A Targeted Approach to Recruitment Enrollment and Retention”, addresses how digital marketing techniques can be used to recruit, control and retain enrolled participants in clinical trials. An Oncology and Neuroscience Researcher, Entrepreneur and Technologist, Bethany founded AutoCruitment to fulfill a vision of utilizing the power of the internet to address recruitment, enrollment and retention problems in clinical trials.
AutoCruitment is able to provide a path to effective digital marketing presence through a proprietary and targeted, direct-to-patient, online marketing platform that targets, recruits, screens and automatically refers new patients for clinical trials or specialty medical procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers.
Bray has 10 years of experience in Pharmaceutical Research, Operations and Business Development and holds a BSc in Pharmacology, a Masters in Translational Medicine & Neuroscience from Imperial College London and an MBA from the Georgia Institute of Technology.
For more information on the DIA 2016 Annual Meeting and Conference and how you can participate click on http://www.diaglobal.org/.
Originally formed in 2013 as NeuroCruitment with a sole focus on neurological diseases and recruitment for clinical trials, the benefits and effectiveness of the company’s unique web-based software platform quickly attracted CROs, sponsors and research sites addressing other therapeutic areas as well as Hospitals, Cancer Centers and Physicians groups looking to increase revenues through new patient referrals for specialty procedures. The company changed its name in early 2015 to AutoCruitment and expanded its offering; referring patients for both clinical trials and specialty procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers. Clients are not the only ones to benefit from expediting the recruiting process; the platform empowers people who are suffering from chronic illness or disease with the ability to locate specialist providers and/or enroll in applicable clinical trials that offer access to potentially life-changing medical advances.
For more information contact AutoCruitment at email@example.com